Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension (HEXA)

University of Zurich (UZH)

Status: Completed

Conditions: Hypertension, Pulmonary

Treatments: Other: Placebo-ambient air (FiO2 21%); Other: Normobaric hypoxia (FiO2 15%)

Study type: Interventional

Funder types: Other

Identifiers

NCT04697875

2020-02163_A1

Details and patient eligibility

About

To study hemodynamic effects of acute normobaric hypoxia during exercise in patients with pulmonary hypertension in a single-center randomized controlled trial.

Enrollment: 24 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Informed consent as documented by signature (Appendix Informed Consent Form)
• PH class I (PAH) or IV (CTEPH) diagnosed according to guidelines: mean pulmonary artery pressure >20 mmHg, pulmonary vascular resistance ≥3 wood units, pulmonary arterial wedge pressure ≤15 mmHg during baseline measures at the diagnostic right-heart catheterization

Exclusion criteria

• resting partial pressure of oxygen <8 kilopascal at Zürich altitude on ambient air
• exposure to an altitude >1000 m for ≥3 nights during the last 2 weeks before the study
• inability to follow the procedures of the study
• patients who take nitrates
• other clinically significant concomitant end-stage disease (e.g., renal failure, hepatic dysfunction)

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

24 participants in 2 patient groups

Normobaric hypoxia (FiO2 15%)

Experimental group

Treatment:

Other: Normobaric hypoxia (FiO2 15%)

Placebo-ambient air (FiO2 21%)

Sham Comparator group

Treatment:

Other: Placebo-ambient air (FiO2 21%)